The Journal of Bone and Joint Surgery (American). 2006;88:295-302.
doi:10.2106/JBJS.E.00193
© 2006 The Journal of Bone and Joint Surgery, Inc.
Sodium Hyaluronate in the Treatment of Osteoarthritis of the Ankle: A Controlled, Randomized, Double-Blind Pilot Study
Robert S. Salk, DPM1,
Thomas J. Chang, DPM1,
Walter F. D'Costa, DPM2,
David J. Soomekh, DPM3 and
Kirk A. Grogan, DPM1
1 45 Castro Street, Suite #315, San Francisco, CA 94114. E-mail address for R.
Salk:
drsalk{at}yahoo.com.
E-mail address for T. Chang:
changgang5{at}aol.com.
E-mail address for K. Grogan:
kagrogan{at}yahoo.com
2 2281 Cleveland Avenue, Santa Rosa, CA 95403. E-mail address:
noshib{at}aol.com
3 2121 Wilshire Boulevard, Suite #101, Santa Monica, CA 90403. E-mail address:
dsoomekh{at}hotmail.com
Investigation performed at the Northern California Foot and Ankle
Center, San Francisco and Santa Rosa, California
A commentary is available with the electronic versions of this article,
on our web site
(www.jbjs.org)
and on our quarterly CD-ROM (call our subscription department, at
781-449-9780, to order the CD-ROM).
Note: The authors thank Sara Dahle, MPH, and Huong Le, MPH, for their
assistance in statistical analysis.
In support of their research for or preparation of this manuscript, one or
more of the authors received grants or outside funding from Sanofi-Aventis,
Inc. None of the authors received payments or other benefits or a commitment
or agreement to provide such benefits from a commercial entity. No commercial
entity paid or directed, or agreed to pay or direct, any benefits to any
research fund, foundation, educational institution, or other charitable or
nonprofit organization with which the authors are affiliated or
associated.
Background: Intra-articular injections of hyaluronans have been
shown to be safe and effective for the treatment of pain associated with
osteoarthritis of the knee. This pilot study was undertaken to gather
preliminary data on the efficacy and safety of five weekly intra-articular
injections of Hyalgan (sodium hyaluronate; molecular weight, 500 to 730 kDa)
as compared with saline solution for the treatment of pain associated with
osteoarthritis of the ankle.
Methods: Twenty patients at two test sites were randomized
with use of a double-blind (blinded observer), saline solution-controlled,
parallel experimental design. Patients were randomized to receive five weekly
intra-articular injections of either 1 mL of sodium hyaluronate (10 mg/mL) or
1 mL of phosphate-buffered saline solution into the ankle joint. The primary
outcome measurement was the ankle osteoarthritis score. Several secondary
outcome measures also were assessed.
Results: Significant improvement in the mean ankle osteoarthritis
score from baseline was seen at all follow-up visits from one to six months in
both the sodium hyaluronate group and the saline solution group (p <
0.0001). In addition, five of nine patients in the sodium hyaluronate group
had >30 mm of improvement in this score, compared with one of eight
patients in the control group. No withdrawals were directly attributable to
the injections of sodium hyaluronate or saline solution, and no severe
medication-related adverse events were observed.
Conclusions: The present study suggests that five weekly
intra-articular injections of sodium hyaluronate (molecular weight, 500 to 730
kDa) are well tolerated, can provide sustained relief of pain, and can improve
function in patients with osteoarthritis of the ankle. These findings are
consistent with those of previously published studies involving
intra-articular injections of sodium hyaluronate in other joints, but they
require confirmation in a large, randomized, saline solution-controlled
study.
Level of Evidence: Therapeutic Level I. See Instructions
to Authors for a complete description of levels of evidence.

CiteULike Connotea Del.icio.us Facebook Technorati Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
P. F. O'Loughlin, B. E. Heyworth, and J. G. Kennedy
Current Concepts in the Diagnosis and Treatment of Osteochondral Lesions of the Ankle
Am. J. Sports Med.,
February 1, 2010;
38(2):
392 - 404.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. J. Strauss, J. A. Hart, M. D. Miller, R. D. Altman, and J. E. Rosen
Hyaluronic Acid Viscosupplementation and Osteoarthritis: Current Uses and Future Directions
Am. J. Sports Med.,
August 1, 2009;
37(8):
1636 - 1644.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. V. Cheung, R. Adams, and B. F. Morrey
Primary Osteoarthritis of the Elbow: Current Treatment Options
J. Am. Acad. Ortho. Surg.,
February 1, 2008;
16(2):
77 - 87.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. A. Alade and M. S. Mizel
What's New in Foot and Ankle Surgery
J. Bone Joint Surg. Am.,
April 1, 2007;
89(4):
914 - 921.
[Full Text]
[PDF]
|
 |
|
|